India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body says

India's pharmaceutical industry is likely to miss its sales target for the end of the decade as U.S. tariff uncertainty and Middle East ​shipping disruptions weigh on exports, the head of a government-backed trade body ‌told Reuters.